Literature DB >> 16410264

Epidemiological MIC cut-off values for tigecycline calculated from Etest MIC values using normalized resistance interpretation.

Göran Kronvall1, Inga Karlsson, Mats Walder, Mikael Sörberg, Lennart E Nilsson.   

Abstract

OBJECTIVES: To apply the normalized resistance interpretation (NRI) method to Etest MIC results which have higher precision than conventional log2 dilution MIC tests due to the inclusion of intermediate values. If successful, NRI might provide an objective tool for the definition of epidemiological MIC cut-off values.
METHODS: MICs of tigecycline and other antimicrobial agents were determined for 4771 clinical isolates comprising five Gram-positive and 13 Gram-negative species or species groups using the Etest. Histograms of MIC values were constructed for each species and NRI calculations were applied to them. An upper MIC limit of 2.5 SD above the theoretical mean of the normalized distribution was used for setting the epidemiological cut-off values.
RESULTS: Calculated cut-off values for wild-type strains were between 0.11 and 0.96 mg/L for Gram-positive species, and between 0.44 and 8.3 mg/L for Gram-negative species, except for Pseudomonas aeruginosa, which had a cut-off value of 450 mg/L, consistent with earlier reports on the lack of activity of tigecycline against this species.
CONCLUSIONS: NRI offers an objective method for the analysis of MICs produced using Etests and the determination of epidemiological MIC cut-off values.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16410264     DOI: 10.1093/jac/dki489

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  Normalized resistance interpretation as a tool for establishing epidemiological MIC susceptibility breakpoints.

Authors:  Göran Kronvall
Journal:  J Clin Microbiol       Date:  2010-10-06       Impact factor: 5.948

2.  Statistical methods for establishing quality control ranges for antibacterial agents in Clinical and Laboratory Standards Institute susceptibility testing.

Authors:  John Turnidge; Gerry Bordash
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

Review 3.  Setting and revising antibacterial susceptibility breakpoints.

Authors:  John Turnidge; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

4.  National surveillance of methicillin-resistant Staphylococcus aureus in China highlights a still-evolving epidemiology with 15 novel emerging multilocus sequence types.

Authors:  Meng Xiao; He Wang; Ying Zhao; Lei-Li Mao; Mitchell Brown; Yun-Song Yu; Matthew V N O'Sullivan; Fanrong Kong; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

5.  Independent emergence of colistin-resistant Enterobacteriaceae clinical isolates without colistin treatment.

Authors:  Shudan Chen; Fupin Hu; Xuelian Zhang; Xiaogang Xu; Yang Liu; Demei Zhu; Honghai Wang
Journal:  J Clin Microbiol       Date:  2011-09-07       Impact factor: 5.948

6.  Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.

Authors:  Ronald N Jones; Mary Jane Ferraro; L Barth Reller; Paul C Schreckenberger; Jana M Swenson; Helio S Sader
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

7.  Epidemiological Cut-Off Values and Multidrug Resistance of Escherichia coli Isolated from Domesticated Poultry and Pigs Reared in Mwanza, Tanzania: A Cross-Section Study.

Authors:  Conjester I Mtemisika; Helmut Nyawale; Ronald J Benju; Joseph M Genchwere; Vitus Silago; Martha F Mushi; Joseph Mwanga; Eveline Konje; Mariam M Mirambo; Stephen E Mshana
Journal:  Animals (Basel)       Date:  2022-03-25       Impact factor: 2.752

8.  Combination of alpha-melanocyte stimulating hormone with conventional antibiotics against methicillin resistant Staphylococcus aureus.

Authors:  Madhuri Singh; Ravisekhar Gadepalli; Benu Dhawan; Kasturi Mukhopadhyay
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

9.  Pediatric fecal microbiota harbor diverse and novel antibiotic resistance genes.

Authors:  Aimée M Moore; Sanket Patel; Kevin J Forsberg; Bin Wang; Gayle Bentley; Yasmin Razia; Xuan Qin; Phillip I Tarr; Gautam Dantas
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.